SEC Form D · filed October 6, 2016
Lysosomal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Bernard Davitian · Cambridge, MADirectorCornelis Been · Cambridge, MAExec · DirectorRobert Carpenter · Cambridge, MAExec · DirectorBruce L. Booth · Cambridge, MADirectorSteven E. Hall · Cambridge, MADirectorCarole E. Nuechterlein · Cambridge, MADirectorClay E. Thorp · Cambridge, MADirectorTerrell L. Winstead · Jackson, MSDirectorLukasz Gottwald · El Segundo, CAExec · Director22Nw Fund GP, LLC · Seattle, WAExec · DirectorBruce L. Booth · Cambridge, MADirectorAnabatic Investment Partners, LLC · Oak Brook, ILDirector22Nw, LP · Seattle, WAExec · DirectorRussell J. Matthews · Denver, CODirectorWarren J. Olsen · Denver, CODirectorDavid Bree · GEORGETOWN, GRAND CAYMAN, Cayman IslandsExec · DirectorThomas E. Lynch · Boca Raton, FLDirectorTammy Savage · Seattle, WADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗